We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $206B
1-Year Est. Return 31.61%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
+9.71%
1 Year Est. Return
+31.61%
3 Year Est. Return
+91.73%
5 Year Est. Return
+103.23%
10 Year Est. Return
+394.96%
AUM
$54.9B
AUM Growth
-$1.43B
Cap. Flow
-$10.1B
Cap. Flow %
-18.32%
Top 10 Hldgs %
15.84%
Holding
4,613
New
106
Increased
2,539
Reduced
1,420
Closed
185

Sector Composition

Rank Sector Weight
1 Technology 7.73%
2 Financials 5.47%
3 Healthcare 4.96%
4 Consumer Discretionary 4.64%
5 Industrials 3.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FOXA icon
3726
PUT
Fox Class A
FOXA
$26.5B
$33.4K ﹤0.01%
9
OPBK icon
3727
OP Bancorp
OPBK
$235M
$33.2K ﹤0.01%
3,200
+1,177
+58% +$11.6K
VHC icon
3728
VirnetX Holding Corp
VHC
$65.8M
$33.1K ﹤0.01%
436
-44
-9% -$4.42K
SBT
3729
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$33K ﹤0.01%
4,080
+697
+21% +$6.48K
TBIO
3730
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$33K ﹤0.01%
4,052
-671
-14% -$6.19K
AKCA
3731
DELISTED
Akcea Therapeutics Inc
AKCA
$32.8K ﹤0.01%
1,935
-672
-26% -$12.5K
MGA icon
3732
Magna International
MGA
$18.6B
$32.4K ﹤0.01%
591
-374
-39% -$20.3K
CLCT
3733
DELISTED
Collectors Universe
CLCT
$32.2K ﹤0.01%
1,396
+381
+38% +$10.2K
LXU icon
3734
LSB Industries
LXU
$711M
$32.2K ﹤0.01%
9,952
+5,388
+118% +$18.2K
KALV
3735
DELISTED
KalVista Pharmaceuticals
KALV
$32.1K ﹤0.01%
1,801
+327
+22% +$4.27K
MCHX icon
3736
Marchex
MCHX
$77.5M
$32K ﹤0.01%
8,466
+4,087
+93% +$14.7K
NERV icon
3737
Minerva Neurosciences
NERV
$187M
$31.9K ﹤0.01%
561
-41
-7% -$1.81K
SGC icon
3738
Superior Group of Companies
SGC
$213M
$31.9K ﹤0.01%
2,358
+791
+50% +$11.4K
IMXI icon
3739
International Money Express
IMXI
$343M
$31.8K ﹤0.01%
2,645
+1,009
+62% +$13.7K
UNB icon
3740
Union Bankshares
UNB
$120M
$31.6K ﹤0.01%
872
+216
+33% +$7.35K
FRTA
3741
DELISTED
Forterra, Inc
FRTA
$31.5K ﹤0.01%
2,727
-320
-11% -$3.11K
CRK icon
3742
Comstock Resources
CRK
$4.09B
$31.5K ﹤0.01%
3,822
-105,536
-97% -$737K
OVLY icon
3743
Oak Valley Bancorp
OVLY
$283M
$31.4K ﹤0.01%
1,616
+487
+43% +$8.63K
SRT
3744
DELISTED
Startek Inc.
SRT
$31.4K ﹤0.01%
3,934
+1,877
+91% +$13.7K
CHA
3745
DELISTED
China Telecom Corporation, LTD
CHA
$31.3K ﹤0.01%
761
+76
+11% +$3.19K
CLVS
3746
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
$31.3K ﹤0.01%
30
ARLP icon
3747
Alliance Resource Partners
ARLP
$3.23B
$31.2K ﹤0.01%
2,880
LEVL
3748
DELISTED
Level One Bancorp, Inc. Common Stock
LEVL
$31.1K ﹤0.01%
1,237
+391
+46% +$9.6K
RLGT icon
3749
Radiant Logistics
RLGT
$400M
$31.1K ﹤0.01%
5,580
-683
-11% -$3.69K
SFE
3750
DELISTED
Safeguard Scientifics, Inc.
SFE
$31K ﹤0.01%
2,822
-302
-10% -$3.45K

Similar funds

BNP Paribas Financial Markets's Q4 2019 Portfolio in Review

As of Q4 2019, BNP Paribas Financial Markets held 4,613 positions worth $54.9B, down 2.5% from $56.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

BNP Paribas Financial Markets withdrew a net $10.1B in Q4 2019, closing 185 positions and reducing 1,420 holdings. Its most notable exit was Celgene Corp, an estimated $56.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.3% a quarter earlier, followed by Financials and Healthcare.

Against the trend, BNP Paribas Financial Markets opened a new position in iShares US Financials ETF worth $124M.

  • BNP Paribas Financial Markets's largest Q4 2019 buy was iShares US Financials ETF: 1,800,000 shares worth $124M.
  • BNP Paribas Financial Markets added most to Bristol-Myers Squibb in Q4 2019, an estimated $140M increase.
  • BNP Paribas Financial Markets's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
  • BNP Paribas Financial Markets fully exited Celgene Corp in Q4 2019, selling an estimated $56.8M.
  • BNP Paribas Financial Markets's ten largest holdings make up 16% of its $54.9B portfolio in Q4 2019.
  • BNP Paribas Financial Markets opened 106 new positions and closed 185 in Q4 2019.
  • BNP Paribas Financial Markets's portfolio value fell 2.5% quarter-over-quarter to $54.9B.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.